Australia  

Khabib vs. Georges St-Pierre Was Late Father's Dream, Trainer Says

TMZ.com Saturday, 24 October 2020
It's starting to make more sense why Khabib Nurmagomedov so badly wants to fight Georges St-Pierre -- it was his father's plan. Khabib's dad, Abdulmanap Nurmagomedov, passed away back in July after battling COVID. Khabib and his dad were extremely…
0
shares
ShareTweetSavePostSend
 
Video Credit: PA - Press Association STUDIO - Published
News video: Khabib Nurmagomedov retires from UFC

Khabib Nurmagomedov retires from UFC 00:49

Conor McGregor has paid tribute to his UFC rival Khabib Nurmagomedov, who hasannounced he is retiring from the octagon. Nurmagomedov extended his perfectprofessional record to 29-0 with a second-round submission win over JustinGaethje at UFC 254. After his victory, Nurmagomedov announced his...

You Might Like


💡 One News Page Knowledge: Other News Mentions

Khabib Nurmagomedov Khabib Nurmagomedov Russian professional mixed martial artist

Dana White Betting on Khabib Fighting Again, Names 4 Possible Opponents

Dana White is doubling down on his claim Khabib Nurmagomedov will return to the Octagon -- and he's willing to put his money where his mouth is! "If I had to..
TMZ.com

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Moderna's COVID-19 Vaccine Designed Designed In 2 Days [Video]

Moderna's COVID-19 Vaccine Designed Designed In 2 Days

Moderna's coronavirus vaccine candidate is 94.5% effective at protecting people against COVID-19. The candidate took under a year to develop and test, which is years faster than previous vaccines. The company designed its vaccine candidate in just two days, says Business Insider. In contrast, traditional vaccines can take years to design. Vaccines will hopefully be rolled out by Spring of 2021.

Credit: Wochit News    Duration: 00:33Published
Questions over AstraZeneca's COVID-19 vaccine data [Video]

Questions over AstraZeneca's COVID-19 vaccine data

British drugmaker AstraZeneca is working with regulators to investigate a lower dosage of its vaccine that performed better than a full dosage, a spokesman for the company said on Thursday, after its chief executive was quoted as saying an additional global trial was likely. This report produced by Jillian Kitchener.

Credit: Reuters - Politics    Duration: 01:29Published
Dosing Mix-up Raises Questions About New COVID Vaccine [Video]

Dosing Mix-up Raises Questions About New COVID Vaccine

A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed. The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford. Less than a week after we learned about it, the developers have admitted to a manufacturing error. The error resulted from two different doses during the recently concluded phase III trial. AstraZeneca and the University of Oxford described the vaccine as being 70% effective.

Credit: Wochit News    Duration: 00:39Published
Elephant safari resumes in Jaipur's Amer Fort [Video]

Elephant safari resumes in Jaipur's Amer Fort

Elephant rides at Jaipur's Amer Fort resumed after months-long closure. The rides were prohibited due to COVID pandemic. Mahouts breathed a sigh of relief after state govt granted permission. Elephant safari is one of the key attractions at famous Amer Fort.

Credit: ANI    Duration: 02:02Published